Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,492,182
-
Share change
-
+482,134
-
Total reported value
-
$398,275,105
-
Put/Call ratio
-
81%
-
Price per share
-
$114.04
-
Number of holders
-
112
-
Value change
-
+$56,018,406
-
Number of buys
-
56
-
Number of sells
-
51
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2017
As of 30 Jun 2017,
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,492,182 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, Navellier & Associates Inc, LPL Financial LLC, ROYAL BANK OF CANADA, AMERIPRISE FINANCIAL INC, J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD, and RAYMOND JAMES & ASSOCIATES.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.